Source: Marketing Authorisation Holder Publisher: Oethmaan Biosims (PTY) Ltd., 207A Sherwood House, Greenacres Office Park, c/o Victory and Rustenburg Roads, Victory Park, Johannesburg 2195
Pharmacological classification: A 20.1.2 Penidllins.
(i) Spectrum
Amoxycillin is a penicillinase-susceptible penicillin and is, therefore, contra-indicated in infections caused by penicillinase-producing organisms. ULTRAMOX exhibits in vitro, and in experimental animals in vivo, bactericidal activity against a wide range of Gram-negative and Gram-positive organisms including:
Gram-positive bacteria: | Gram-negative bacteria: |
Staphylococcus aureus (penicillin-sensitive) | Neisseria gonorrhoeae |
Streptococcus pyogenes | Neisseria meningitidis |
Streptococcus viridans | Haemophilus influences |
Streptococcus faecalis | Bordetella pertussis |
Diplococcus pneumoniae | Escherichia coli |
Corynebacterium species | Salmonella typhi |
Clostridium species | Salmonella species |
Bacillus anthracis | Shigella species |
Brucella suedes | |
Proteus mirabilis |
(ii) Bactericidal
In Vitro: ULTRAMOX exerts a more rapid bactericidal action than other beta-lactam antibiotics against susceptible Escherichia coli. At similar inhibitory concentrations, ULTRAMOX results in a greater degree of bacterial cell lysis than other beta-lactam antibiotics against susceptible E. coll.
In Vivo: ULTRAMOX has been shown to exert greater therapeutic activity than ampicillin at similar blood levels in certain experimental infections.
ULTRAMOX is extremely well absorbed orally. mAfter oral administration, there is no significant difference between the peak serum levels in fasting and non-fasting subjects. The presence of food does not interfere with the absorption of ULTRAMOX. ULTRAMOX may, therefore, be taken with meals. There is a linear/dose response in peak serum levels after oral administration.
i) Sputum: The concentration of amoxycillin in sputum does not decrease as occurs with ampicill in as purulence subsides.
ii) Bile: ULTRAMOX is present in bile obtained from a common bile duct drain of a healthy gall-bladder, however binary levels are lower when the gall-bladder is diseased and absent in the presence of binary tract obstruction.
iii) Urine: The average concentration of ULTRAMOX in urine collected during the first six hours after a 250 mg oral dose, is 580 pg/ml
iv) CSF: There is insufficient evidence at present to show that ULTRAMOX penetrates into the cerebra-spinal fluid in therapeutic quantities and it should, therefore, not be used in the treahnent of cerebra-spinal infections.
i) Renal: Approximately 60% of an oral dose of ULTRAMOX is excreted unchanged in the active form into the urine within six hours.
ii) Biliary: Avariable percentage of ULTRAMOX is excreted into the bile.
Even higher ULTRAMOX serum levels may be achieved after oral administration to patients with normal renal function, by the simultaneous administration of a renal blocking agent such as probenecid. Probenecid should not be given in the presence of abnormal renal function.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.